Product Introduction

• lopamiro®(lopamidol)

  
  

  • The first generation non-ionic iodine contrast agent in 1981;

  • Low permeability, viscosity and bio-toxicity, perfect combination of high hydrophilicity;

  • The world's first 370mgl/ml product on the market.
  High-concentration iodine contrast agent;

  • A large number of evidence-based medical studies confirmed the high safety for heart and kidney.

  
  
  

  lomeron®(lomeprol)

  
  

  • A new generation of non-ionic iodine contrast agent without chelating agents (CaNa2EDTA);

  • The only reference listed contrast agent product approved by CFDA for interventional coronary angiography1;

  • The best enhancement effect, providing the most precise diagnostic imaging;

  
  
  

  MultiHance®(Gadobenate dimegiumine)

  
  

  • A new generation of non-ionic iodine contrast agent without chelating agents (CaNa2EDTA);

  • Obvious enhancement advantages in the detection of small hepatocellular carcinoma;

  • Better enhancement effects if applied to all parts of the body.

  
  
  

• ProHance®(Gadoteridol)

  
  

  • Annular non-ionic maaocyclic gadolinium MRI contrast agent widely used in the world;

  • Lowest osmotic pressure and viscosity of gadolinium in the market, and excellent stability in vivo;

  • No contraindications for liver and kidney.

  
  
  

  SonoVue®(Sulphur hexafluoride)

  
  

  • Leader in contrast-en-hanced ultrasound in China;

  • Product in NRDL;

  • Sulphur Hexafluoride Microbubbles do not contain human protein composition;

  • Pure blood pool contrast agent, almost completely eliminated by breathing after 15 minutes;

  • No skin test, no metabolism via liver or kidney and no contraindications for liver and kidney.

  • Imported technology without refrigeration;

  • Approved by 40 countries, applicable to various indications;

  • 15 years in the Chinese market, choice of thousands of hospitals and millions of patients.

Empower CTA®

• EmpowerCTA® contrast agent injector system is aimed at connecting to CT scanners, injecting ionic/non-ionic mixtures and flushing media.

Empower MR®

• Empower MR® contrast agent injector system is aimed at meeting the ever growing needs for magnetic resonance, whose product specifications cover.

ACIST CVi®

• The Bracco contrast agent delivery system can simplify contrast agent injection for a variety of coronary artery surgeries - not only suitable for small dose injection into coronary arteries, but also large dose injection into ventricular and peripheral blood vessels. Angio Touch can help achieve accurate.

Itroduction of Syringes

The main products EmpowerCTA®, EmpowerMR® and ACIST CVi® of Bracco provide patients with simpler procedures, more efficient operation and safer physical examination. In addition, both the injector data management system and high pressure injector solutions with a large amount of real evidence can provide patients with more information to facilitate them to make decisions on medical treatment. Among them, the general agency of.